Atsuro Nakazato

MGS0039: a potent and selective group II metabotropic glutamate receptor antagonist with antidepressant-like activity

Shigeyuki Chaki, Ryoko Yoshikawa, Shiho Hirota et al. · Neuropharmacology · 2003 · 250 citations

Antidepressant-like Activity, Psychoactive Drug, Psychiatry +11

Design, synthesis and structure–affinity relationships of aryloxyanilide derivatives as novel peripheral benzodiazepine receptor ligands

Taketoshi Okubo, Ryoko Yoshikawa, Shigeyuki Chaki et al. · Bioorganic & Medicinal Chemistry · 2003 · 156 citations

Molecular Pharmacology, Pharmaceutical Chemistry, Derivatives +8

Receptor Binding, Behavioral, and Electrophysiological Profiles of Nonpeptide Corticotropin-Releasing Factor Subtype 1 Receptor Antagonists CRA1000 and CRA1001

Shigeru Okuyama, Shigeyuki Chaki, Naoya Kawashima et al. · Journal of Pharmacology and Experimental Therapeutics · 1999 · 153 citations · Full text

Anxiolytic- and antidepressant-like profile of a new CRF1 receptor antagonist, R278995/CRA0450

Shigeyuki Chaki, Atsuro Nakazato, Ludo Kennis et al. · European Journal of Pharmacology · 2003 · 123 citations

Molecular Pharmacology, Antidepressant-like Profile, Psychiatry +9

NE-100, a novel sigma receptor ligand: In vivo tests

Shigeru Okuyama, Yasuko Imagawa, Shinichi Ogawa et al. · Life Sciences · 1993 · 120 citations

Autoimmune Disease, Novel Therapy, Medicine +6